Identification of Blood Erythroid Markers Useful in Revealing Erythropoietin Abuse in Athletes

Krantz, 1991, Erythropoietin, Blood., 77, 419, 10.1182/blood.V77.3.419.419

Kirby, 1996, Proliferation of multipotent hematopoietic cells controlled by truncated erythropoietin receptor transgene, Proc. Natl. Acad. Sci. USA, 93, 9402, 10.1073/pnas.93.18.9402

Liboi, 1993, Erythropoietin receptor signals both proliferation and erythroid-specific differentiation, Proc. Natl. Acad. Sci. USA, 90, 11351, 10.1073/pnas.90.23.11351

Watowich, 1992, Homodimerization and constitutive activation of the erythropoietin receptor, Proc. Natl. Acad. Sci. USA, 89, 2140, 10.1073/pnas.89.6.2140

Lacombe, 1998, Biology of erythropoietin, Haematologica, 83, 724

Klingmuller, 1996, Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5, Proc. Natl. Acad. Sci. USA, 93, 8324, 10.1073/pnas.93.16.8324

Lasne, 2000, Recombinant erythropoietin in urine, Nature, 405, 635, 10.1038/35015164

Flaharty, 1990, Clinical pharmacology of recombinant human erythropoietin (rHuEpo), Pharmacotherapy, 10, 9S, 10.1002/j.1875-9114.1990.tb02567.x

Flaharty, 1990, Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men, Clin. Pharmacol. Ther., 47, 557, 10.1038/clpt.1990.76

Gareau, 1996, Erythropoietin abuse in athletes, Nature, 380, 113, 10.1038/380113a0

Feelders, 1999, Structure, function and clinical significance of transferrin receptors, Clin. Chem. Lab. Med., 37, 1, 10.1515/CCLM.1999.001

Bhandari, 1997, Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy, Am. J. Kidney Dis., 30, 814, 10.1016/S0272-6386(97)90087-1

Beguin, 1993, Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen, Blood, 82, 2010, 10.1182/blood.V82.7.2010.2010

Fullerton, 1994, Molecular and population genetic analysis of allelic sequence diversity at the human β-globin locus, Proc. Natl. Acad. Sci. USA, 91, 1805, 10.1073/pnas.91.5.1805

Vu, 2000, A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis, Nucleic Acids Res., 28, 1, 10.1093/nar/28.7.e18

Dacie, 1975

Unknown 1991Le Mond Cycliste23, 10–12.

Adamson, 1991, Recombinant erythropoietin to improve athletic performance, N. Engl. J. Med., 324, 698, 10.1056/NEJM199103073241014

Lippi, 2000, Laboratory screening for erythropoietin abuse in sport: An emerging challenge, Clin. Chem. Lab. Med., 38, 13, 10.1515/CCLM.2000.003

Audran, 1999, Effects of erythropoietin administration in training athletes and possible indirect detection in doping control, Med. Sci. Sports Exerc., 31, 639, 10.1097/00005768-199905000-00003

Ahn, 1993, Origin of a soluble truncated transferrin receptor, Blood, 81, 2442, 10.1182/blood.V81.9.2442.2442

Skikne, 1998, Circulating transferrin receptor assay—Coming of age, Clin. Chem., 44, 7, 10.1093/clinchem/44.1.7

Spivak, 1994, Recombinant human erythropoietin and the anemia of cancer, Blood, 84, 997, 10.1182/blood.V84.4.997.997

Magnani, 1999, Monitoring erythropoietin abuse in athletes, Br. J. Haematol., 106, 260, 10.1046/j.1365-2141.1999.01575.x